Skip to main content
. 2013 Nov 27;3(5):436–441. doi: 10.1038/kisup.2013.91

Table 1. Changes in circulating MBD marker levels during 3 years of follow-up.

  Intact PTH
Phosphorus
Calcium
Visit number (time period) Median (pg/ml) Percentage of achievement of target Mean (s.d.) (mg/dl) Percentage of achievement of target Mean (s.d.) (mg/dl) Percentage of achievement of target
0 (up to Dec 2007) 265 14.5 5.53 (1.37) 63.3 9.45 (0.88) 65.5
1 (Jan 2008 to Mar 2008) 259 21.7 5.57 (1.39) 61.9 9.45 (0.85) 68.6
2 (Apr 2008 to Jun 2008) 225 30.8 5.49 (1.35) 65.2 9.49 (0.83) 69.5
3 (Jul 2008 to Sep 2008) 187 38.6 5.34 (1.37) 65.7 9.58 (0.82) 67.5
4 (Oct 2008 to Dec 2008) 189 38.2 5.41 (1.38) 65.6 9.55 (0.79) 69.4
5 (Jan 2009 to Mar 2009) 191 37.6 5.56 (1.41) 62.1 9.46 (0.80) 72.1
6 (Apr 2009 to Jun 2009) 172 42.3 5.44 (1.36) 64.4 9.51 (0.78) 70.8
7 (Jul 2009 to Sep 2009) 160 45.0 5.27 (1.37) 67.1 9.56 (0.81) 68.5
8 (Oct 2009 to Dec 2009) 172 40.9 5.39 (1.39) 65.0 9.51 (0.77) 71.4
9 (Jan 2010 to Mar 2010) 173 41.6 5.52 (1.37) 63.7 9.47 (0.75) 73.6
1 0 (Apr 2010 to Jun 2010) 165 42.5 5.47 (1.36) 65.3 9.50 (0.76) 73.1
11 (Jul 2010 to Sep 2010) 150 46.1 5.24 (1.34) 69.1 9.58 (0.77) 71.0
12 (Oct 2010 to Dec 2010) 160 44.1 5.32 (1.36) 67.7 9.52 (0.74) 73.5

Abbreviations: MBD, mineral and bone disorder; PTH, parathyroid hormone.

Target levels of serum calcium, phosphorus, and intact PTH were defined as 8.4–10.0 mg/dl, 3.5–6.0 mg/dl, and 60–180 pg/ml, respectively.